GUIDELINES FOR AUTISM
The British Association for Psychopharmacology (BAP) has recently produced guidelines on the assessment and treatment of autism spectrum disorder. With a lack of high-quality trials, advice has been based on consensus rather than systematic reviews. The guidelines emphasise plans, regular review and psychosocial interventions rather than drugs. Unlike the National Institute for Health and Care Excellence (NICE) guidance, BAP does recommend use of melatonin for disordered sleep.
Howes O, Rogdaki M, Findon J. et al. (2018) Autism spectrum disorder: Consensus guidelines on assessment treatment and research from the British Association for Psychopharmacology. Journal of Psychopharmacology 32(1): 3–29.
Conclusion: The British Association for Psychopharmacology emphasise plans, regular review and psychosocial interventions in the treatment of autism spectrum disorder rather than drugs, and recommend use of melatonin for disordered sleep.Visit Details